NCT03244215 - The Recurrence Study | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

February 17, 2016

Primary Completion Date

February 17, 2018

Study Completion Date

May 17, 2018

Conditions

Acute StrokeTransient Ischemic Attack

Interventions

DIAGNOSTIC_TEST

Corneal Confocal Imaging

Retinal imaging will be ordered for all subjects in the study group. Corneal

DIAGNOSTIC_TEST

Magnetic resonance Imaging

MRI will be ordered for all study subjects at the completion of their participation at year 1. The MRI will assess the the progression or regression of the cerebrovascular health of the study subjects.

OTHER

Blood sample

Blood samples will be obtained to evaluate the levels of blood inflammatory biomarkers in both the subjects and control group.

Trial Locations (1)

3500

RECRUITING

The Neuroscience Institute, Hamad Medical Corporation, Doha